Mary Theresa Coelho - Net Worth and Insider Trading

Mary Theresa Coelho Net Worth

The estimated net worth of Mary Theresa Coelho is at least $174,066 dollars as of 2024-11-05. Mary Theresa Coelho is the See Remarks of BioDelivery Sciences International Inc and owns about 30,619 shares of BioDelivery Sciences International Inc (BDSI) stock worth over $171,160. Mary Theresa Coelho is also the EVP CFO & Chief BD Officer of CinCor Pharma Inc and owns about 100 shares of CinCor Pharma Inc (CINC) stock worth over $2,906. Details can be seen in Mary Theresa Coelho's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mary Theresa Coelho has not made any transactions after 2022-01-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Mary Theresa Coelho

Mary Theresa Coelho Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mary Theresa Coelho owns 7 companies in total, including BioDelivery Sciences International Inc (BDSI) , Balchem Corp (BCPC) , and Gamida Cell Ltd (GMDAQ) among others .

Click here to see the complete history of Mary Theresa Coelho’s form 4 insider trades.

Insider Ownership Summary of Mary Theresa Coelho

Ticker	Comapny	Transaction Date	Type of Owner
BDSI	BioDelivery Sciences International Inc	2021-02-01	See Remarks
BCPC	Balchem Corp	2017-10-23	Chief Financial Officer
GMDAQ	Gamida Cell Ltd	2023-05-22	Chief Financial Officer
		2023-01-03	director
		2022-01-11	EVP CFO & Chief BD Officer
		2023-04-03	director
		2023-10-16	director

Mary Theresa Coelho Latest Holdings Summary

Mary Theresa Coelho currently owns a total of 2 stocks. Among these stocks, Mary Theresa Coelho owns 30,619 shares of BioDelivery Sciences International Inc (BDSI) as of February 1, 2021, with a value of $171,160 and a weighting of 98.33%. Mary Theresa Coelho also owns 100 shares of CinCor Pharma Inc (CINC) as of January 11, 2022, with a value of $2,906 and a weighting of 1.67%.

Latest Holdings of Mary Theresa Coelho

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
BDSI	BioDelivery Sciences International Inc	2021-02-01	30,619	5.59	171,160
CINC	CinCor Pharma Inc	2022-01-11	100	29.06	2,906

Holding Weightings of Mary Theresa Coelho

Mary Theresa Coelho Form 4 Trading Tracker

According to the SEC Form 4 filings, Mary Theresa Coelho has made a total of 3 transactions in BioDelivery Sciences International Inc (BDSI) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in BioDelivery Sciences International Inc is the sale of 3,460 shares on February 1, 2021, which brought Mary Theresa Coelho around $13,390.

According to the SEC Form 4 filings, Mary Theresa Coelho has made a total of 1 transactions in CinCor Pharma Inc (CINC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in CinCor Pharma Inc is the acquisition of 100 shares on January 11, 2022, which cost Mary Theresa Coelho around $1,600.

Insider Trading History of Mary Theresa Coelho

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mary Theresa Coelho Trading Performance

GuruFocus tracks the stock performance after each of Mary Theresa Coelho's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mary Theresa Coelho is 22.44%. GuruFocus also compares Mary Theresa Coelho's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mary Theresa Coelho within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mary Theresa Coelho's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mary Theresa Coelho

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	50.59
Relative Return to S&P 500(%)	56.84

Mary Theresa Coelho Ownership Network

Ownership Network List of Mary Theresa Coelho

No Data

Ownership Network Relation of Mary Theresa Coelho

Mary Theresa Coelho Owned Company Details

What does BioDelivery Sciences International Inc do?

Who are the key executives at BioDelivery Sciences International Inc?

Mary Theresa Coelho is the See Remarks of BioDelivery Sciences International Inc. Other key executives at BioDelivery Sciences International Inc include See Remarks James Vollins , director & Chief Executive Officer Jeffrey Allen Bailey , and See Remarks Scott M. Plesha .

BioDelivery Sciences International Inc (BDSI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of BioDelivery Sciences International Inc (BDSI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioDelivery Sciences International Inc (BDSI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BioDelivery Sciences International Inc (BDSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

BioDelivery Sciences International Inc Insider Transactions

No Available Data

What does Balchem Corp do?

Who are the key executives at Balchem Corp?

Mary Theresa Coelho is the Chief Financial Officer of Balchem Corp. Other key executives at Balchem Corp include Vice President Van Gunsteren Job Leonard , Chief Accounting Officer William A. Backus , and Chief Technology Officer Michael Robert Sestrick .

Balchem Corp (BCPC) Insider Trades Summary

Over the past 18 months, Mary Theresa Coelho made no insider transaction in Balchem Corp (BCPC). Other recent insider transactions involving Balchem Corp (BCPC) include a net sale of 35,984 shares made by William A. Backus , a net sale of 13,029 shares made by Michael Robert Sestrick , and a net sale of 8,800 shares made by David B Fischer .

In summary, during the past 3 months, insiders sold 0 shares of Balchem Corp (BCPC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 136,264 shares of Balchem Corp (BCPC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 136,264 shares.

Balchem Corp (BCPC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Balchem Corp Insider Transactions

No Available Data

What does Gamida Cell Ltd do?

Who are the key executives at Gamida Cell Ltd?

Mary Theresa Coelho is the Chief Financial Officer of Gamida Cell Ltd. Other key executives at Gamida Cell Ltd include CMO & Chief Scientific Officer Ronit Simantov , director & President and CEO Abigail L. Jenkins , and 10 percent owner Len Blavatnik .

Gamida Cell Ltd (GMDAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Gamida Cell Ltd (GMDAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Gamida Cell Ltd (GMDAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Gamida Cell Ltd (GMDAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Gamida Cell Ltd Insider Transactions

No Available Data

What does Entero Therapeutics Inc do?

Who are the key executives at Entero Therapeutics Inc?

Mary Theresa Coelho is the director of Entero Therapeutics Inc. Other key executives at Entero Therapeutics Inc include Chief Financial Officer Sarah Romano , director & President and CEO James Sapirstein , and CHIEF FINANCIAL OFFICER Daniel H Schneiderman .

Entero Therapeutics Inc (ENTO) Insider Trades Summary

Over the past 18 months, Mary Theresa Coelho made no insider transaction in Entero Therapeutics Inc (ENTO). Other recent insider transactions involving Entero Therapeutics Inc (ENTO) include a net sale of 4,066 shares made by Sarah Romano , a net sale of 6,280 shares made by James Sapirstein , and a net sale of 6,063 shares made by Charles J Casamento .

In summary, during the past 3 months, insiders sold 476 shares of Entero Therapeutics Inc (ENTO) in total and bought 0 shares, with a net sale of 476 shares. During the past 18 months, 6,431 shares of Entero Therapeutics Inc (ENTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,431 shares.

Entero Therapeutics Inc (ENTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Entero Therapeutics Inc Insider Transactions

No Available Data

What does CinCor Pharma Inc do?

Who are the key executives at CinCor Pharma Inc?

Mary Theresa Coelho is the EVP CFO & Chief BD Officer of CinCor Pharma Inc. Other key executives at CinCor Pharma Inc include director & 10 percent owner James Healy , 10 percent owner Sofinnova Management X-a, L.l.c. , and EVP & Chief Financial Officer Michael Wayne Kalb .

CinCor Pharma Inc (CINC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CinCor Pharma Inc (CINC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CinCor Pharma Inc (CINC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CinCor Pharma Inc (CINC)'s detailed insider trading history can be found in Insider Trading Tracker table.

CinCor Pharma Inc Insider Transactions

No Available Data

What does HOOKIPA Pharma Inc do?

Who are the key executives at HOOKIPA Pharma Inc?

Mary Theresa Coelho is the director of HOOKIPA Pharma Inc. Other key executives at HOOKIPA Pharma Inc include director & Chief Financial Officer Reinhard Kandera , director & Chief Executive Officer Jorn Aldag , and Chief Medical Officer Katia Schlienger .

HOOKIPA Pharma Inc (HOOK) Insider Trades Summary

Over the past 18 months, Mary Theresa Coelho made no insider transaction in HOOKIPA Pharma Inc (HOOK). Other recent insider transactions involving HOOKIPA Pharma Inc (HOOK) include a net purchase of 27,000 shares made by Reinhard Kandera , and a net purchase of 20,000 shares made by Jorn Aldag .

In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HOOKIPA Pharma Inc (HOOK) were sold and 4,700 shares were bought by its insiders, resulting in a net purchase of 4,700 shares.

HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

HOOKIPA Pharma Inc Insider Transactions

No Available Data

What does Inotiv Inc do?

Who are the key executives at Inotiv Inc?

Mary Theresa Coelho is the director of Inotiv Inc. Other key executives at Inotiv Inc include Chief Operating Officer John Gregory Beattie , Chief Commercial Officer Michael Garrett , and SVP & Gen. Counsel & Secretary Andrea Castetter .

Inotiv Inc (NOTV) Insider Trades Summary

Over the past 18 months, Mary Theresa Coelho made no insider transaction in Inotiv Inc (NOTV). Other recent insider transactions involving Inotiv Inc (NOTV) include a net purchase of 47,966 shares made by John Gregory Beattie , and a net purchase of 5,000 shares made by Michael Garrett .

In summary, during the past 3 months, insiders sold 0 shares of Inotiv Inc (NOTV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inotiv Inc (NOTV) were sold and 52,966 shares were bought by its insiders, resulting in a net purchase of 52,966 shares.

Inotiv Inc (NOTV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inotiv Inc Insider Transactions

No Available Data

Mary Theresa Coelho Mailing Address

Above is the net worth, insider trading, and ownership report for Mary Theresa Coelho. You might contact Mary Theresa Coelho via mailing address: 52 Sunrise Park Road, New Hampton Ny 43017.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.